New vans to service hospitals
New vans to service hospitals 4th February 2025

The first of our new look transits hit the road last week!

 

The vans, which join the fleet of vehicles that deliver to our hospital customers nationwide, have a greater payload capacity, meaning we can transport more medicines on fewer journeys which saves fuel and positively impacts the environment.

 

This is in line with our green agenda and the NHS’s Evergreen sustainability initiative. As we continue our journey to reduce carbon emissions, our focus is to provide the same first-rate service that we are renowned for in a state-of-the art fleet specified for the transportation of medicines to our customers. Key features include:

 

Dual temperature – control chambers that align to GDP

 

Solar panels that generate electricity to save fuel

 

Live streaming / cloud based, front facing recording camera

 

 

If you want to know more about the unrivalled support we can provide to hospitals email info@mawdsleys.co.uk

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-now-one-of-two-wholesalers-to-supply-b-braun-products-into-hospitals/ thumbnail image Mawdsleys now one of two wholesalers to Supply B Braun products into hospitals

We are delighted to be able to confirm that Mawdsleys, as of October 2017, as is one of two wholesalers selected by B Braun to supply their range of products into secondary care.   With Mawdsleys you will benefit from: - Industry-leading 22 days average stock holding - EDI or…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.